Searched for
ASTRAZENECA PHARMA Q4
ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- HDFC Bank shares in focus as RBI approves 3-month extension for Keki Mistry as interim chairmanHDFC Bank's interim chairman, Keki Mistry, has received a three-month extension from the RBI until September 18, 2026, easing concerns abou...
- Accenture cuts revenue outlook, stock crashes 17%Accenture has lowered its annual revenue growth forecast. Companies are still cautious about spending on technology. This is happening even...
- Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
- Bajaj Auto sets June 24 as record date for Rs 5,632 crore share buyback. Here’s all you need to knowBajaj Auto has set June 24 as the record date for its substantial Rs 5,633 crore share buyback. Shareholders will be eligible to tender sha...
- Yes Bank shares jump 16% in 5 days, hit fresh 52-week high. What lies ahead?Yes Bank shares climbed to a fresh 52-week high, extending gains over five sessions and adding Rs 8,662 crore to market value. The rally fo...
- Dixon Tech shares rally 5% amid reports of government nod for Vivo JV this monthDixon Technologies shares surged rose sharply on Wednesday after reports suggested the government may approve its long-pending joint ventur...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- India adds 4.6 GWh of energy storage capacity in first quarter of 2026: ReportIndia saw a massive surge in battery energy storage capacity in early 2026. The country added 4.6 gigawatt-hours in the first three months,...
- India Inc's sales growth gathers pace in March quarter, led by autos and metals: RBI dataManufacturing companies saw sales jump 14.5 percent in the fourth quarter of 2025-26. Automobiles, electrical machinery, and non-ferrous me...
- Automobiles, electrical machinery push sales of listed private manufacturing companies in Q4: RBI dataIndian manufacturing companies saw sales jump 14.5 percent in early 2026. Automobiles, electrical machinery, and metals led this growth. Ov...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- India a major growth market for Celonis, says senior execThe Germany-based company said it already serves 260 global capability centres (GCCs) in India, counting companies such as Mercedes-Benz, H...
- The AI play no one is talking about: Why BofA is snapping up power & metals instead of ITBofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...
Load More
